Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Nutcracker Therapeutics Appoints Cynthia Collins, Biopharma Veteran and Former Editas Medicine CEO, to Board of Directors
Nutcracker Therapeutics, a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology […]
CANbridge Pharmaceuticals Appoints Jason West Vice President, Head of Gene Therapy Research
CANbridge Pharmaceuticals, a global biopharmaceutical company, with a foundation in China, committed to the research, […]
Modalis Therapeutics to Present Data for Muscular Dystrophy Treatment
Modalis Therapeutics, a pioneering company developing innovative products for the treatment of rare genetic diseases […]
Function Oncology Launches to Transform the Future of Targeted Cancer Treatment with CRISPR
Function Oncology, a precision medicine company advancing a CRISPR-powered personalized functional genomics platform to transform […]
Sherlock Biosciences Appoints Maurice Exner as Chief Scientific Officer
Sherlock Biosciences, a company engineering biology to bring next-generation diagnostics to the point-of-need, today announced that […]
Synthego Launches Express Cell Pools for Faster, More Efficient Genome Editing
Synthego, a leading provider of genome engineering solutions, has announced the launch of Express Knockout […]
Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics
Trobix Bio, a company utilizing CRISPR, phage, and synthetic biology technologies to develop advanced precision […]
Synthego Introduces CRISPR Discovery Partners to Streamline CRISPR-Driven Drug Discovery Research
Synthego, a leading genome engineering solutions provider, announced today the launch of its service partner […]
Vesigen Therapeutics Awarded Grant from Friedreich’s Ataxia Research Alliance (FARA) to Develop a Targeted Genome Editing Therapeutic Strategy
Vesigen Therapeutics, a biotechnology company developing targeted therapies by engineering a distinct class of human […]
Sherlock Biosciences Acquires Sense Biodetection Advancing CRISPR-Based Diagnostics for Consumers
Sherlock Biosciences, a company engineering biology to bring next-generation diagnostics to the point of need, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more